-
Cell biology
Lee-Thedieck section
-
Cell Physiology and Biophysics
Ngezahayo section
-
Biostatistics
Schaarschmidt section
-
Computational Biology
Rudorf section
-
Biofabrication for Drug Testing
Egger section
Publications of our sections
Complete list
Showing results 441 - 450 out of 459
Lalla, S., Hothorn, L. A., Haag, N., Bader, R., & Bauss, F. (1998). Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats. Osteoporosis international, 8(2), 97-103. https://doi.org/10.1007/BF02672503
Ngezahayo, A., Zeilinger, C., Todt, I., Marten, I., & Kolb, H.-A. (1998). Inactivation of expressed and conducting rCx46 hemichannels by phosphorylation. Pflugers Archiv European Journal of Physiology, 436(4), 627-9. https://doi.org/10.1007/s004240050681
Hothorn, L. A., & Martin, U. (1997). Application of adaptive interim analysis in pharmacology. Therapeutic Innovation & Regulatory Science, 31(2), 615-619. https://doi.org/10.1177/009286159703100229, https://doi.org/10.15488/2981
Hothorn, L. A. (1997). Guest editor's note: Biostatistics in preclinical studies. Therapeutic Innovation & Regulatory Science, 31(2), 321-322. https://doi.org/10.1177/009286159703100201, https://doi.org/10.15488/3010
Hothorn, L. A. (1997). Modifications of the closure principle for analyzing toxicological studies. Therapeutic Innovation & Regulatory Science, 31(2), 403-412. https://doi.org/10.1177/009286159703100211, https://doi.org/10.15488/3022
Hothorn, L. A., Lin, K. K., Hamada, C., & Rebel, W. (1997). Recommendations for biostatistics of repeated toxicity studies. Therapeutic Innovation & Regulatory Science, 31(2), 327-334. https://doi.org/10.1177/009286159703100203, https://doi.org/10.1177/009286159703100203
Kropf, S., Hothorn, L. A., & Läuter, J. (1997). Multivariate many-to-one procedures with applications to preclinical trials. Therapeutic Innovation & Regulatory Science, 31(2), 433-447. https://doi.org/10.1177/009286159703100214, https://doi.org/10.15488/3023
Neuhäuser, M., & Hothorn, L. A. (1997). The control of the consumer risk in the Ames assay. Drug Information Journal, 31(2), 363-367. https://doi.org/10.1177/009286159703100207, https://doi.org/10.15488/3052
Neuhäuser, M., & Hothorn, L. A. (1997). Trend tests for dichotomous endpoints with application to carcinogenicity studies. Therapeutic Innovation & Regulatory Science, 31(2), 463-469. https://doi.org/10.1177/009286159703100217, https://doi.org/10.15488/3057
Hauschke, D., Steinijans, V. W., & Hothorn, L. A. (1996). A note on Welch's approximate t-solution to bioequivalence assessment. BIOMETRIKA, 83(1), 236-237. https://doi.org/10.1093/biomet/83.1.236
Showing results 441 - 450 out of 459
